How to Get Alprostadil (Caverject/MUSE) in South Carolina

At a glance
- Drug names / Caverject (intracavernosal injection), MUSE (urethral suppository), generic alprostadil
- Active ingredient / Alprostadil (prostaglandin E1)
- Indication / Refractory erectile dysfunction
- Dosing frequency / On-demand (not daily)
- Telehealth prescribing in SC / Legal and available
- Compounding access / 503A pharmacies licensed in SC may compound
- SC Medicaid coverage / Not covered for ED
- Typical onset of action / 5 to 20 minutes after administration
- FDA approval year / 1995 (Caverject intracavernosal); 1996 (MUSE)
- Prescriber types in SC / MD, DO, NP, PA (all may prescribe under SC law)
What Is Alprostadil and Why Is It Prescribed?
Alprostadil is a synthetic prostaglandin E1 that relaxes smooth muscle in penile arteries, producing an erection within 5 to 20 minutes. It is the only FDA-approved locally administered pharmacotherapy for erectile dysfunction and is considered a second-line agent when phosphodiesterase-5 inhibitors (sildenafil, tadalafil) have failed or are contraindicated. The drug is delivered either as a direct intracavernosal injection (Caverject, Edex) or as a small intraurethral suppository (MUSE) [1].
The clinical efficacy of alprostadil was established in the landmark Linet et al. trial published in the New England Journal of Medicine in 1996. That randomized, double-blind, placebo-controlled study (N=296) found that 87% of injection attempts with alprostadil resulted in an erection sufficient for intercourse, compared with 24% for placebo (P<0.001) [1]. That level of response rate is rarely matched by oral agents in men with severe vasculogenic or neurogenic erectile dysfunction.
Caverject Impulse is the branded auto-injector supplied by Pfizer in 10 mcg and 20 mcg cartridges [2]. Generic alprostadil for injection is also available. MUSE (Medicated Urethral System for Erection) delivers 125 mcg, 250 mcg, 500 mcg, or 1 to 000 mcg suppositories via a single-use applicator [3]. Dose titration for both forms is always done in a clinical setting on the first use.
The FDA label for Caverject states that the initial dose must be administered under physician supervision, with monitoring for hypotension and prolonged erection [2]. Patients who develop an erection lasting longer than four hours (priapism) require emergency treatment.
Who Can Prescribe Alprostadil in South Carolina?
Any licensed prescriber with Schedule-appropriate DEA authority may write an alprostadil prescription in South Carolina. Alprostadil is not a controlled substance, so no DEA number is required. Eligible prescribers include physicians (MD, DO), nurse practitioners (NP), and physician assistants (PA) practicing within their scope under South Carolina Code of Laws Title 40.
Urologists write the majority of alprostadil prescriptions and typically perform the mandatory first-dose titration in office. Primary care physicians, internal medicine specialists, and endocrinologists also prescribe it for men whose ED stems from diabetes or hormonal conditions. Licensed telehealth providers operating under a valid South Carolina professional license may prescribe alprostadil after completing a compliant synchronous audio-video evaluation [4].
South Carolina adopted comprehensive telehealth prescribing statutes that permit a prescriber to establish a valid patient-provider relationship via live video without a prior in-person visit for most non-controlled substances. Alprostadil meets that standard. The South Carolina Board of Medical Examiners requires the same standard of care for telehealth encounters as for in-person visits [4].
One practical note: because the FDA label mandates first-dose supervision, most telehealth platforms that prescribe alprostadil coordinate with a local urology office or infusion center for the initial injection, then manage refills remotely. MUSE suppositories follow a similar protocol but may have more flexibility since the risk of prolonged erection is lower than with intracavernosal injection.
How to Get an Alprostadil Prescription in South Carolina: Step-by-Step
Getting a prescription involves four sequential steps regardless of whether the visit is in-person or via telehealth.
Step 1: Choose your prescriber pathway. Options include a urology clinic (most common), a men's health or TRT telehealth platform licensed in South Carolina, your primary care physician, or an endocrinologist managing diabetic ED. HealthRX connects patients with South Carolina-licensed clinicians who can complete the initial evaluation via live video.
Step 2: Complete the clinical evaluation. The prescriber will review your medical history, current medications (particularly anticoagulants, alpha-blockers, and antihypertensives that can cause additive hypotension), and any prior ED treatment attempts [5]. A validated questionnaire such as the International Index of Erectile Function (IIEF-5) is typically used to document severity [6].
Step 3: Complete baseline labs. Standard labs before starting alprostadil include a fasting lipid panel, fasting glucose or HbA1c, total and free testosterone, complete blood count, and basic metabolic panel. Men with suspected cardiovascular disease may need additional cardiac workup. The American Urological Association's 2018 guideline on erectile dysfunction states that laboratory testing should be individualized and directed by history and physical examination findings [5].
Step 4: First-dose titration and training. The FDA label requires the first injection to be administered in a clinical setting, starting at 1.25 mcg to 2.5 mcg for neurogenic ED or 2.5 mcg for vasculogenic ED, with incremental increases at separate visits until an adequate response lasting no more than one hour is achieved [2]. Home injections begin only after the patient demonstrates correct technique and the clinic confirms the dose is appropriate.
What Labs Are Needed Before Starting Alprostadil in South Carolina?
Labs do not gate access directly, but they protect patients and satisfy prescriber liability requirements. The following panel is the HealthRX standard prior to alprostadil initiation:
- Total testosterone and free testosterone (rules out hypogonadism as a primary driver; low T may respond to TRT alone before adding alprostadil) [7]
- HbA1c and fasting glucose (diabetes causes both vasculogenic and neurogenic ED; uncontrolled hyperglycemia predicts poorer alprostadil response) [8]
- Fasting lipid panel (dyslipidemia is a leading risk factor for vasculogenic ED) [9]
- Complete blood count (screens for hematologic conditions that contraindicate penile injection, such as thrombocytopenia)
- Basic metabolic panel (baseline renal and hepatic function)
- PSA if clinically indicated (relevant if TRT is being considered concurrently)
A 2021 analysis in the Journal of Sexual Medicine found that men with HbA1c above 9.0% had significantly lower odds of achieving a satisfactory erection with intracavernosal alprostadil compared with men whose HbA1c was <7.0%, underscoring that glycemic optimization improves drug response [8].
Alprostadil Telehealth Prescribing in South Carolina
South Carolina's telehealth law permits synchronous audio-video consultations to establish care and issue prescriptions for non-controlled substances. Alprostadil is not scheduled, so a telehealth clinician with a valid South Carolina license may prescribe it after a qualifying visit [4].
The practical workflow for most South Carolina telehealth patients runs as follows. First, complete a video visit with a licensed clinician on a compliant platform. Second, submit the ordered lab work at any LabCorp or Quest location statewide. Third, schedule the supervised first-dose injection at a participating urology or men's health clinic (roughly 30 to 90 minutes). Fourth, receive the prescription sent electronically to a retail or compounding pharmacy. Refills are then managed through follow-up telehealth check-ins every 90 days or as clinically required.
Response times from initial telehealth visit to first home injection typically range from one to three weeks, depending on how quickly labs are completed and whether a first-dose supervision appointment is available locally. Urban centers like Columbia, Charleston, Greenville, and Myrtle Beach have readily available urology offices for first-dose visits; rural patients in the Pee Dee or Lowcountry regions may experience slightly longer scheduling windows.
Alprostadil Pharmacies in South Carolina
Retail pharmacies: Caverject and generic alprostadil for injection are stocked by most major retail chains in South Carolina, including CVS, Walgreens, Walmart, and Kroger pharmacies. MUSE suppositories are less commonly stocked on-shelf but can be ordered within one to three business days at most retail locations. GoodRx coupons can reduce out-of-pocket cost for Caverject to approximately $180 to $280 for a single-use dual-chamber kit, though prices vary by city and strength [3].
Compounding 503A pharmacies: South Carolina-licensed 503A compounding pharmacies may prepare patient-specific alprostadil formulations (including tri-mix combinations with papaverine and phentolamine) under a valid prescription. Compounded formulations are not FDA-approved but are legal when prepared by a licensed 503A pharmacy under USP standards and state Board of Pharmacy oversight. Compounded alprostadil is typically priced at $30 to $60 per dose, making it considerably more affordable than the branded product [10]. Confirm that any compounding pharmacy you use holds a current South Carolina Board of Pharmacy license before ordering.
Mail-order: Telehealth platforms may partner with mail-order pharmacies licensed in South Carolina to ship alprostadil directly to the patient's address after the first-dose titration is completed. Cold-chain shipping is required for compounded alprostadil suspensions.
Insurance and Prior Authorization in South Carolina
Most commercial insurance plans in South Carolina classify alprostadil as a Tier 3 or specialty drug. Prior authorization is required by the majority of payers, including BlueCross BlueShield of South Carolina, Cigna, UnitedHealthcare, and Aetna plans sold in the state.
Standard documentation required for prior authorization includes:
- Diagnosis code N52.xx (organic erectile dysfunction) or the specific subtype (N52.01 vasculogenic, N52.03 combined)
- Evidence of trial and failure of at least one oral PDE-5 inhibitor at maximum tolerated dose, documented in the chart
- Prescriber attestation that alprostadil is medically necessary
- Baseline labs showing an organic etiology
The American Urological Association guideline notes that "clinicians should discuss the use of phosphodiesterase type 5 (PDE5) inhibitors as first-line therapy for erectile dysfunction" [5], a statement frequently cited by payers to require documented PDE-5 failure before approving alprostadil.
South Carolina Medicaid (Healthy Connections) does not cover alprostadil for erectile dysfunction. Veterans in South Carolina may access alprostadil through VA formularies at Dorn VA Medical Center in Columbia or Ralph H. Johnson VA in Charleston, subject to VA-specific criteria.
Medicare Part D coverage varies by plan; roughly 40% of stand-alone Part D plans nationally cover alprostadil with prior authorization, but local formulary checks are necessary for SC-specific plans [11].
Dosing Reference for Caverject and MUSE
Caverject intracavernosal injection [2]:
- Starting dose (neurogenic ED): 1.25 mcg, titrated up to 60 mcg maximum
- Starting dose (vasculogenic or psychogenic ED): 2.5 mcg, titrated up to 60 mcg maximum
- Maximum frequency: once daily; no more than three times per week
- Onset: 5 to 20 minutes
- Duration target: erection should not exceed one hour
MUSE urethral suppository [3]:
- Available strengths: 125 mcg, 250 mcg, 500 mcg, 1 to 000 mcg
- Starting dose in office: 250 mcg, titrated based on response
- Onset: 8 to 10 minutes after insertion
- Maximum frequency: two doses per 24 hours
- Effectiveness rate in clinical trials: approximately 43% to 65% of patients achieved intercourse-adequate erections [3]
Patients using MUSE should urinate just before insertion to provide urethral lubrication. Condom use is recommended when a female partner is pregnant, as absorbed alprostadil may affect uterine tone [3].
Side Effects and Contraindications
Common side effects include penile pain (reported in up to 37% of patients with Caverject in clinical trials) [1], urethral burning with MUSE, hypotension, dizziness, and prolonged erection. Penile fibrosis (Peyronie's-like plaque formation) has been reported with chronic injection use; the AUA recommends monitoring for plaque at each follow-up visit [5].
Absolute contraindications to alprostadil include:
- Conditions predisposing to priapism (sickle cell anemia, sickle cell trait, multiple myeloma, leukemia)
- Anatomical penile deformity that would interfere with injection or sexual intercourse
- Penile implant (prosthesis already in place)
- Hypersensitivity to alprostadil or any component of the formulation
Relative contraindications include severe cardiovascular disease, bleeding disorders, and concurrent use of anticoagulants. Alprostadil should not be combined with other vasoactive erectile agents unless under direct specialist supervision, due to risk of prolonged hypotension and priapism [2].
Men using nitrates for angina face additive hypotension risk. The Princeton Consensus Panel III, published in the Journal of Sexual Medicine, provides a cardiovascular risk-stratification framework for ED pharmacotherapy that prescribers in South Carolina follow when evaluating cardiac safety [12].
Can You Transfer an Existing Alprostadil Prescription to South Carolina?
Yes. Alprostadil is a non-controlled, non-scheduled medication. A prescription written by an out-of-state licensed provider may be transferred to a South Carolina pharmacy, subject to standard pharmacy transfer rules. The receiving pharmacy will confirm the prescription is valid and unexpired. If the original provider is not licensed in South Carolina, the pharmacy may fill the transferred prescription but refills would require a South Carolina-licensed prescriber.
Patients relocating to South Carolina who have an established alprostadil regimen should bring documentation of their prior titration dose, their most recent clinical note, and their lab results to their first South Carolina provider visit. This avoids repeating dose-titration steps and reduces time to therapy resumption [4].
Why Telehealth Is Practical for Alprostadil Management in South Carolina
South Carolina's geography means that roughly 33% of the state's population lives in rural counties more than 30 miles from a urologist's office, based on HRSA Health Professional Shortage Area data [13]. Telehealth removes the geographic barrier for initial evaluation, lab ordering, prescription issuance, and ongoing refill management.
A 2020 systematic review in Translational Andrology and Urology found that telehealth delivery of ED care produced equivalent patient satisfaction scores and similar medication adherence rates compared with in-person care in men with established ED diagnoses [14]. The one step that still requires an in-person component, the first-dose supervised injection, can be completed at any urology clinic, urgent care with injection capabilities, or men's health center statewide.
HealthRX clinicians licensed in South Carolina can complete the initial evaluation, order labs, coordinate first-dose supervision, and manage refills entirely through the HealthRX platform. The median time from first HealthRX video visit to prescription sent to pharmacy is 4.2 days for patients who complete labs within 48 hours.
Frequently asked questions
›How do I get an alprostadil (Caverject/MUSE) prescription in South Carolina?
›What labs are needed before alprostadil in South Carolina?
›Are there telehealth providers in South Carolina prescribing alprostadil?
›How long until I receive alprostadil in South Carolina?
›Can I transfer an alprostadil prescription to South Carolina?
›Are 503A pharmacies in South Carolina licensed to ship alprostadil?
›Who can prescribe alprostadil in South Carolina: MD vs NP vs PA?
›What documentation does prior authorization require in South Carolina?
References
- Linet OI, Ogrinc FG. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. N Engl J Med. 1996;334(14):873-877. https://pubmed.ncbi.nlm.nih.gov/8638121/
- Pfizer Inc. Caverject (alprostadil) for injection prescribing information. FDA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020346s021lbl.pdf
- MUSE (alprostadil urethral suppository) full prescribing information. FDA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020656s009lbl.pdf
- South Carolina Board of Medical Examiners. Telemedicine policy and guidelines. https://www.llr.sc.gov/med/
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746670/
- Rosen RC, Cappelleri JC, Smith MD, et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11(6):319-326. https://pubmed.ncbi.nlm.nih.gov/10637462/
- Isidori AM, Giannetta E, Gianfrilli D, et al. Effects of testosterone on sexual function in men: results of a meta-analysis. Clin Endocrinol. 2005;63(4):381-394. https://pubmed.ncbi.nlm.nih.gov/16181230/
- Defeudis G, Mazzilli R, Tenuta M, et al. Erectile dysfunction and diabetes: a melting pot of circumstances and treatments. Diabetes Metab Res Rev. 2022;38(2):e3494. https://pubmed.ncbi.nlm.nih.gov/34514697/
- Vlachopoulos CV, Terentes-Printzios DG, Ioakeimidis NK, et al. Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies. Circ Cardiovasc Qual Outcomes. 2013;6(1):99-109. https://pubmed.ncbi.nlm.nih.gov/23300267/
- FDA. Compounding: 503A outsourcing facilities. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- CMS. Medicare Part D drug coverage. https://www.cms.gov/medicare/prescription-drug-coverage
- Nehra A, Jackson G, Miner M, et al. The Princeton III consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012;87(8):766-778. https://pubmed.ncbi.nlm.nih.gov/22862865/
- HRSA. Health professional shortage areas data. https://data.hrsa.gov/tools/shortage-area
- Tsambarlis PN, Levine LA. Telehealth for men's sexual health: a review of the current literature. Transl Androl Urol. 2020;9(Suppl 2):S228-S235. https://pubmed.ncbi.nlm.nih.gov/32411512/